Crimson President to Address International Compliance Conference

Live Blogging Featured from Re-Launched Crimson Website

Boston & San Francisco, March 5, 2010

Crimson Life Sciences, the specialized medical device division of global language and business services leader TransPerfect, today announced that the company’s president, Marc H. Miller, will present at a full-day industry conference hosted by the New England Biomedical Division of the American Society for Quality (ASQ). The conference, titled “International Compliance: Supporting Global Medical Device Marketing Initiatives beyond the US, Canada & Europe,” will take place on Thursday, March 11, at the Waltham Woods Conference Center—agenda and registration information can be found here.

Focusing on regions outside of traditional overseas markets, the ASQ-Biomedical conference will address such key topics as:

  • Establishing internal and external partnerships for device approvals and compliance
  • Trade regulations and medical device export information
  • Key characteristics of a medical device global quality compliance system
  • Global regulatory updates for medical device manufacturers

Miller will deliver a presentation focused on “How to assemble a strong translation and localization process for labeling, customer, and marketing materials.” Explains Miller, “Labeling and marketing materials have critical risk management implications related to both regulatory and business concerns. The regulatory risks, especially, are getting increased notice from Notified Bodies.” According to Miller, understanding these risks is the first step in creating a strong translation process.

Live from the International Compliance Conference

Building on a successful experiment in live blogging, updates will be posted throughout the conference. Says Miller, “Our live blogging from the Opal Medical Device Summit produced a fourfold increase in traffic to Crimson’s Medical Device Translation blog. Clearly, there is an interest from device manufacturers in having access to specific, real-time information of this kind.”

Live posts from the event will commence on the morning of Thursday, March 11, and can be accessed from the Crimson website ( or directly on the Medical Device Translation blog at

About Crimson Life Sciences

Crimson is a division of TransPerfect and is the world’s only translation practice devoted exclusively to Class II and Class III medical devices and List A and List B IVDs. Crimson is the first translation company certified to ISO 13485 and ISO 14971. Crimson is also certified to ISO 9001 and carries unique Notified Body endorsements for labeling translation risk management. TransPerfect is the world’s largest privately held language services provider with 56 offices worldwide. 



Crimson Life Sciences has become
TransPerfect Medical Device Solutions.

You will be redirected to the TransPerfect website in